OAM
MIRM icon

OP Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

OP Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,051
Closed -$282K – 806
2026
Q1 		$282K Sell
3,051
-5,487
-64% -$516K ﹤0.01% 713
2025
Q4 		$674K Buy
+8,538
New +$613K 0.01% 628

Other funds holding MIRM

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
HP
Highlander Partners Dallas, Texas $298M AUM 53.88% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

OP Asset Management's MIRM Position: Q2 2026 in Review

OP Asset Management sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 3,051 shares — an estimated $282K sold.

OP Asset Management first reported a position in MIRM in Q4 2025 and held it in 2 quarters. The position peaked at $674K in Q4 2025. 83 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • OP Asset Management reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • OP Asset Management sold 3,051 Mirum Pharmaceuticals shares in Q2 2026, an estimated $282K.
  • OP Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • OP Asset Management's Mirum Pharmaceuticals position peaked at $674K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.